(Q34318781)

1 August 2017

Towards a clinical use of miRNAs in pancreatic cancer biopsies (English)

1 reference

1 August 2017

1 reference

Adam E Frampton

1

1 reference

1 August 2017

Tamara M H Gall

2

1 reference

1 August 2017

Leandro Castellano

3

1 reference

1 August 2017

Justin Stebbing

4

1 reference

1 August 2017

Long R Jiao

5

1 reference

1 August 2017

Jonathan Krell

6

1 reference

1 August 2017

1 January 2013

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

1 August 2017

1 reference

1 August 2017

13

1 reference

1 August 2017

1

1 reference

1 August 2017

31-34

1 reference

MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer

1 August 2017

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.136

MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.136

mir-17-92, a cluster of miRNAs in the midst of the cancer network

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.136

Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.136

Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.136

Expression profiling identifies microRNA signature in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.136

EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.136

Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.136

MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.136

The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.136

let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.136

miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.136

Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.136

MicroRNA miR-155 is a biomarker of early pancreatic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.136

21 January 2018

Identifiers

DOI

10.1586/ERM.12.136

1 reference

1 August 2017

1 reference